3.DNA flow cytometry in pheochromocytoma and paraganglioma.
Woo Hee JUNG ; Woo Ick YANG ; Chanil PARK ; In Joon CHOI
Yonsei Medical Journal 1992;33(3):249-257
Flow cytometric DNA analysis was performed on 19 adrenal pheochromocytomas and 6 extra-adrenal paragangliomas in parallel with clinical and histopathological review to determine the usefulness of this technique to predict biologic behavior of these tumors. In pheochromocytomas and paragangliomas, tetraploidy or near-tetraploidy occurred in 32% and 33% and aneuploidy in 10% and none respectively. A case of malignant pheochromocytoma had diploid DNA content. Occurrence of aneuploidy or tetraploidy is frequent in clinically benign tumors in conjunction with a marked degree of nuclear atypia and cannot be a predictor of malignancy.
Adolescent
;
Adrenal Gland Neoplasms/*genetics/pathology
;
Adult
;
Age Factors
;
Child
;
DNA, Neoplasm/*analysis
;
Female
;
*Flow Cytometry
;
Human
;
Male
;
Middle Age
;
Mitosis
;
Paraganglioma/*genetics/pathology
;
Pheochromocytoma/*genetics/pathology
;
Ploidies
4.Germline gene testing of the RET, VHL, SDHD and SDHB genes in patients with pheochromocytoma/paraganglioma.
Kai WU ; Yang ZHANG ; Hong ZHANG ; Zeng Huan TAN ; Xiao Hui GUO ; Jian Mei YANG
Journal of Peking University(Health Sciences) 2018;50(4):634-639
OBJECTIVE:
To analyze the germline variations of genes RET, VHL, SDHD and SDHB in patients with pheochromocytoma and/or paraganglioma and to evaluate variations of these genes in Chinese patients.
METHODS:
Patients who were treated in Peking University First Hospital from September 2012 to March 2014 and diagnosed with pheochromocytoma and/or paraganglioma by pathologists were included in this study. Twelve patients were included in total, of whom 11 had pheochromocytoma, and 1 had paraganglioma. Deoxyribonucleic acid (DNA) was extracted from the leukocytes of peripheral blood of the patients. The exons 10, 11, 13-16 of the RET gene, and all exons of VHL, SDHB and SDHD genes and their nearby introns (±20 bp) were amplified with polymerase chain reactions, and the products were sent to a biotechnology company for sequencing. The sequencing results were compared with wildtype sequences of these genes to identify variations. One of the patients was diagnosed with multiple endocrine neoplasia type 2A. A family analysis was performed in his kindred, and his family members received genetic tests for the related variations.
RESULTS:
Three patients were found to have germline gene variations. A c.136C>T (p.R46X) variation of the SDHB gene was found in a patient with malignant pheochromocytoma. A c.1901G>A (C634Y) variation, as well as c.2071G>A (p.G691S) and c.2712C>G (p.S904S) variations of the RET gene were found in a patient with multiple endocrine neoplasia type 2A. After a family analysis, five family members of this patient were found to have the same variations. c.2071G>A (p.G691S) and c.2712C>G (p.S904S) variations of the RET gene were also found in a clinical sporadic patient without evidence of malignancy. A patient with congenital single ventricle malformation and pheochromocytoma was included in this study, and no variation with clinical significance was found in the four genes of this patient.
CONCLUSION
25% (3/12) patients with pheochromocytoma or paraganglioma were found to have missense or nonsense germline gene variations in this study, including the c.136C>T (p.R46X) variation of the SDHB gene, the c.1901G>A (C634Y) variation of the RET gene, and c.2071G>A (p.G691S) and c.2712C>G (p.S904S) variations of the RET gene. The former two variations have already been confirmed to be pathogenic. The existence of these variations in Chinese patients with pheochromocytoma and/or paraganglioma was validated in this study, which supports the conclusion that genetic testing is necessary to be generally performed in patients with pheochromocytoma and/or paraganglioma.
Adrenal Gland Neoplasms/genetics*
;
Genetic Testing
;
Germ-Line Mutation
;
Humans
;
Paraganglioma/genetics*
;
Pheochromocytoma/genetics*
;
Proto-Oncogene Proteins c-ret/genetics*
;
Succinate Dehydrogenase/genetics*
;
Von Hippel-Lindau Tumor Suppressor Protein/genetics*
5.Clinicopathological features and molecular genetic analysis of endolymphatic sac tumor: report of 2 cases.
Qiu RAO ; Xiao-jun ZHOU ; Xing-zao JIN ; Heng-hui MA ; Hang-bo ZHOU ; Zhen-feng LU
Chinese Journal of Pathology 2010;39(6):412-413
Adenoma
;
metabolism
;
pathology
;
Adult
;
Carcinoma, Renal Cell
;
metabolism
;
pathology
;
Diagnosis, Differential
;
Ear Neoplasms
;
complications
;
genetics
;
metabolism
;
pathology
;
surgery
;
Endolymphatic Sac
;
Female
;
Follow-Up Studies
;
Humans
;
Kidney Neoplasms
;
metabolism
;
pathology
;
Middle Aged
;
Paraganglioma
;
metabolism
;
pathology
;
Point Mutation
;
Von Hippel-Lindau Tumor Suppressor Protein
;
genetics
;
von Hippel-Lindau Disease
;
complications
;
genetics
;
metabolism